These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Indications for intracardiac electrophysiologic studies in patients with supraventricular tachycardia. Prystowsky EN Circulation; 1987 Apr; 75(4 Pt 2):III119-24. PubMed ID: 3829348 [No Abstract] [Full Text] [Related]
5. Successful treatment for various arrhythmias in an older patient treated with pilsicainide for paroxysmal supraventricular tachycardia. Etoh R; Ishimatsu T; Kawano H; Tomichi Y; Arakawa S; Doi Y; Fukae S; Maemura K Geriatr Gerontol Int; 2018 Oct; 18(10):1520-1521. PubMed ID: 30311445 [No Abstract] [Full Text] [Related]
6. Focal atrial tachycardia: is it yet time for a new paradigm? Singarayar S; Kalman JM J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1394-5. PubMed ID: 15610285 [No Abstract] [Full Text] [Related]
7. [Acute electrophysiologic effects of intravenous ethmozin in patients with paroxysmal supraventricular tachycardia due to WPW syndrome]. Pu JL; Chen X; Sun RL Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Dec; 16(6):329-31, 381-2. PubMed ID: 3073934 [No Abstract] [Full Text] [Related]
8. [Natural history of incessant supraventricular tachycardia in childhood]. López-Gil M; Benito F; Arribas F; Moreno F; García-Fernández F; Pérez-Martínez V Rev Esp Cardiol; 1986; 39 Suppl 1():22-5. PubMed ID: 3797755 [No Abstract] [Full Text] [Related]
9. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia]. Honerjäger P; Schmidt G Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic effects of E-4031, a new class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias. Isomoto S; Shimizu A; Konoe A; Kaibara M; Centurion OA; Fukatani M; Yano K Am J Cardiol; 1993 Jun; 71(16):1464-7. PubMed ID: 8517400 [No Abstract] [Full Text] [Related]
11. Comparative analysis of anti-arrhythmic effect of propranolol and metoprolol in patients with supraventricular tachyarrhythmias. Bobrov VA; Frolov AI; Mitchenko YI; Chervonopiskaya YM; Galichansky IV Rev Port Cardiol; 1993; 12(7-8):611-4, 599. PubMed ID: 8352980 [TBL] [Abstract][Full Text] [Related]
12. Verapamil-induced electrical and cycle length alternans during supraventricular tachycardia: what is the mechanism? Luzza F; Oreto G J Cardiovasc Electrophysiol; 2003 Mar; 14(3):323-4. PubMed ID: 12716120 [No Abstract] [Full Text] [Related]
13. [Supraventricular tachyarrhythmias. Cardiac, extra-cardiac and arrhythmogenic side effects of anti-arrhythmia drugs]. Meinertz T; Willems S; Weiss C Internist (Berl); 1998 Jan; 39(1):33-7. PubMed ID: 9530568 [No Abstract] [Full Text] [Related]
14. Palpitations in a middle-aged woman. Archer TP; Schaal SF; Mazzaferri EL Hosp Pract (1995); 1999 Sep; 34(9):111-4, 118. PubMed ID: 10901764 [No Abstract] [Full Text] [Related]
15. Management of labour and delivery in a woman with refractory supraventricular tachycardia. Dennis AT; Gerstman MD Int J Obstet Anesth; 2014 Feb; 23(1):80-5. PubMed ID: 24360330 [TBL] [Abstract][Full Text] [Related]
16. [Drug therapy and prevention of recurrence of supraventricular tachyarrhythmias]. Steinbigler P; Haberl R; Steinbeck G Internist (Berl); 1998 Jan; 39(1):19-32. PubMed ID: 9530567 [No Abstract] [Full Text] [Related]
17. Chemical cardioversion of supraventricular tachycardia with calcium gluconate. Flagge M; Houry D; Holton B J Emerg Med; 2011 Aug; 41(2):e21-3. PubMed ID: 18757152 [TBL] [Abstract][Full Text] [Related]
18. Reversal of tachycardiomyopathy due to left atrial tachycardia by ivabradine. Bohora S; Lokhandwala Y; Parekh P; Vasavda A J Cardiovasc Electrophysiol; 2011 Mar; 22(3):340-2. PubMed ID: 20653812 [TBL] [Abstract][Full Text] [Related]